Requirements for Regulatory Bioequivalence

The bioequivalence for oral drug is decided in contrast the relative bioavailability of the emblem drug compared to the drug. Food impact bioavailability area unit ordinarily conducted for brand spanking new medication and drug impact throughout the investigational new drug (IND) part to assess the results of food on the speed and proportions of engrossment of a drug once the drug product is management shortly when a meal fed conditions, as compared to commanding underneath diet conditions.

 

  • WHO Approaches
  • FDA Approach and regulations
  • TGA and risk management approach
  • Food-Effect Bioavailability and Fed Bioequivalence Studies

Related Conference of Requirements for Regulatory Bioequivalence

July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
September 14-15, 2026

6th International Conference on Pharmaceutical Chemistry

Paris, France
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland

Requirements for Regulatory Bioequivalence Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in